Haemonetics Corp. has announced it has completed the acquisition of the business assets of Pall Corp.'s blood collection, filtration and processing product lines, according to a news release.
The purchase price is approximately $550 million. The acquired business has approximately 1,300 employees and includes Pall's manufacturing facilities in Covina, Calif.; Tijuana, Mexico; Ascoli, Italy and a portion of Pall's assets in Fajardo, Puerto Rico.
"Today manual whole blood collection is a $1.2 billion global market. This acquisition is an important and exciting step toward our objective of serving that market," said Brian Concannon, Haemonetics' president and CEO, in an April news release about the acquisition. "The Pall business assets provide us with leading filter technology and manufacturing capability, a broad portfolio of manual collection and processing products, a strong and experienced employee base and relationships with major blood authorities and key customers we have in common. Combined with our internal development initiatives to automate whole blood collection and our suite of blood management software, Haemonetics will represent the broadest product offering to address our customers' needs in the whole blood market, a market with more than 60 million procedures per year."
Haemonetics Corp. is headquartered in Braintree, Mass. Pall Corp. is headquartered in Port Washington, N.Y.
Related Articles on Company Acquisitions:
Roper Industries to Acquire Sunquest Information Systems for $1.4B
Alcon Acquires Endure Medical Systems
Hill-Rom Acquires Aspen Surgical Products